These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 24447535)

  • 21. ER-α36: a novel biomarker and potential therapeutic target in breast cancer.
    Su X; Xu X; Li G; Lin B; Cao J; Teng L
    Onco Targets Ther; 2014; 7():1525-33. PubMed ID: 25210466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ER-α36 Interactions With Cytosolic Molecular Network in Acquired Tamoxifen Resistance.
    Teymourzadeh A; Mansouri S; Farahmand L; Hosseinzade A; Majidzadeh-A K
    Clin Breast Cancer; 2017 Oct; 17(6):403-407. PubMed ID: 28433540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opposite regulation of estrogen receptor-α and its variant ER-α36 by the Wilms' tumor suppressor WT1.
    Kang L; Wang L; Wang ZY
    Oncol Lett; 2011; 2(2):337-341. PubMed ID: 22737185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen receptor-α variant, ER-α36, is involved in tamoxifen resistance and estrogen hypersensitivity.
    Zhang X; Wang ZY
    Endocrinology; 2013 Jun; 154(6):1990-8. PubMed ID: 23546601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative profiles of the mRNAs of ER-alpha and its novel variant ER-alpha36 in breast cancers and matched normal tissues.
    Zheng Y; Zhang J; Xu ZZ; Sheng JM; Zhang XC; Wang HH; Teng XD; Liu XJ; Cao J; Teng LS
    J Zhejiang Univ Sci B; 2010 Feb; 11(2):144-50. PubMed ID: 20104649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of ER-α36 in breast cancer by typical xenoestrogens.
    Liu J; Xu Z; Ma X; Huang B; Pan X
    Tumour Biol; 2015 Sep; 36(10):7355-64. PubMed ID: 26337277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional analysis of estrogen receptor alpha variant mRNAs in colorectal cancers and their matched normal colorectal tissues.
    Jiang H; Teng R; Wang Q; Zhang X; Wang H; Wang Z; Cao J; Teng L
    J Steroid Biochem Mol Biol; 2008 Nov; 112(1-3):20-4. PubMed ID: 18703141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A positive cross-regulation of HER2 and ER-α36 controls ALDH1 positive breast cancer cells.
    Kang L; Guo Y; Zhang X; Meng J; Wang ZY
    J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):262-8. PubMed ID: 21907803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen receptor-α36 is involved in icaritin induced growth inhibition of triple-negative breast cancer cells.
    Wang X; Zheng N; Dong J; Wang X; Liu L; Huang J
    J Steroid Biochem Mol Biol; 2017 Jul; 171():318-327. PubMed ID: 28529129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ER-alpha36, a variant of ER-alpha, promotes tamoxifen agonist action in endometrial cancer cells via the MAPK/ERK and PI3K/Akt pathways.
    Lin SL; Yan LY; Zhang XT; Yuan J; Li M; Qiao J; Wang ZY; Sun QY
    PLoS One; 2010 Feb; 5(2):e9013. PubMed ID: 20126312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification, cloning, and expression of human estrogen receptor-alpha36, a novel variant of human estrogen receptor-alpha66.
    Wang Z; Zhang X; Shen P; Loggie BW; Chang Y; Deuel TF
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1023-7. PubMed ID: 16165085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. let-7 microRNAs induce tamoxifen sensitivity by downregulation of estrogen receptor α signaling in breast cancer.
    Zhao Y; Deng C; Lu W; Xiao J; Ma D; Guo M; Recker RR; Gatalica Z; Wang Z; Xiao GG
    Mol Med; 2011; 17(11-12):1233-41. PubMed ID: 21826373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen receptor variant ER-α36 is involved in estrogen neuroprotection against oxidative toxicity.
    Han S; Zhao B; Pan X; Song Z; Liu J; Gong Y; Wang M
    Neuroscience; 2015 Dec; 310():224-41. PubMed ID: 26383254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ER-α36/EGFR signaling loop promotes growth of hepatocellular carcinoma cells.
    You H; Meng K; Wang ZY
    Steroids; 2018 Jun; 134():78-87. PubMed ID: 29481815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen receptor variant ER-α36 promotes tamoxifen agonist activity in glioblastoma cells.
    Qu C; Ma J; Zhang Y; Han C; Huang L; Shen L; Li H; Wang X; Liu J; Zou W
    Cancer Sci; 2019 Jan; 110(1):221-234. PubMed ID: 30417588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chaperone gp96 mediates ER-α36 cell membrane expression.
    Hou J; Deng M; Li X; Liu W; Chu X; Wang J; Chen F; Meng S
    Oncotarget; 2015 Oct; 6(31):31857-67. PubMed ID: 26396174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ER-α variant ER-α36 mediates antiestrogen resistance in ER-positive breast cancer stem/progenitor cells.
    Deng H; Yin L; Zhang XT; Liu LJ; Wang ML; Wang ZY
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():417-26. PubMed ID: 25158023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen Receptor (ER)-α36 Is Involved in Estrogen- and Tamoxifen-Induced Neuroprotective Effects in Ischemic Stroke Models.
    Zou W; Fang C; Ji X; Liang X; Liu Y; Han C; Huang L; Zhang Q; Li H; Zhang Y; Liu J; Liu J
    PLoS One; 2015; 10(10):e0140660. PubMed ID: 26484775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biphasic ER-α36-mediated estrogen signaling regulates growth of gastric cancer cells.
    Wang X; Huang X; Fu Z; Zou F; Li Y; Wang Z; Liu L
    Int J Oncol; 2014 Dec; 45(6):2325-30. PubMed ID: 25231129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Icariin, a phytoestrogen, exerts rapid estrogenic actions through crosstalk of estrogen receptors in osteoblasts.
    Wong KY; Kong TH; Poon CC; Yu W; Zhou L; Wong MS
    Phytother Res; 2023 Oct; 37(10):4706-4721. PubMed ID: 37421324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.